Oncomed Pharma (OMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OMED | AMGN | GILD | VRTX | REGN |
| Company | Oncomed Pharma | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.93 | 310.88 | 64.78 | 402.77 | 958.00 |
| High | 0.93 | 312.73 | 65.56 | 407.59 | 962.10 |
| Low | 0.93 | 297.52 | 64.34 | 401.02 | 950.27 |
| Last | 0.93 | 299.48 | 65.54 | 402.50 | 958.64 |
| Change | +0.04 | -11.81 | +0.76 | +1.42 | +1.64 |
| % Change | +4.49% | -3.79% | +1.17% | +0.35% | +0.17% |
| Volume | 1,201 | 4,717,600 | 7,187,200 | 1,463,600 | 352,000 |
| 20-Day Average Volume | 777,535 | 2,791,225 | 7,536,365 | 1,058,185 | 519,635 |
| Previous Close | 0.89 | 311.29 | 64.78 | 401.08 | 957.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.02 | 273.78 | 66.69 | 398.34 | 910.88 |
| 20-Day Raw Stochastic | 24.44% | 62.66% | 21.53% | 69.30% | 96.02% |
| 20-Day Relative Strength | 48.64% | 62.69% | 34.71% | 48.38% | 59.47% |
| Weighted Alpha | -62.95 | +27.63 | -20.00 | +14.91 | +28.67 |
| Today's Opinion | 24% Sell | 24% Buy | 100% Sell | 8% Buy | 72% Buy |
| Previous Opinion | 40% Sell | 24% Buy | 100% Sell | 8% Buy | 72% Buy |
| Last Month's Opinion | 40% Sell | 8% Sell | 100% Sell | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.82% since 04/16/19 | +8.36% since 04/29/24 | -0.61% since 04/29/24 | +1.59% since 04/29/24 | +7.41% since 04/29/24 |
| Low | 0.82 on 04/17/19 | 272.35 on 04/30/24 | 64.33 on 05/03/24 | 391.70 on 04/30/24 | 885.01 on 04/30/24 |
| High | 1.27 on 04/17/19 | 322.60 on 05/03/24 | 65.89 on 05/01/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 |
| 1-Month | |||||
| %Chg | +5.26% since 03/22/19 | +10.94% since 04/05/24 | -5.81% since 04/05/24 | -1.03% since 04/05/24 | +1.69% since 04/05/24 |
| Low | 0.82 on 04/17/19 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 1.27 on 04/17/19 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 |
| 3-Month | |||||
| %Chg | +27.40% since 01/23/19 | -5.25% since 02/06/24 | -15.67% since 02/06/24 | -3.28% since 02/06/24 | +2.22% since 02/06/24 |
| Low | 0.71 on 02/11/19 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 1.27 on 04/17/19 | 322.60 on 05/03/24 | 76.45 on 02/07/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -55.50% since 10/23/18 | +9.77% since 11/06/23 | -19.23% since 11/06/23 | +4.34% since 11/06/23 | +15.16% since 11/06/23 |
| Low | 0.55 on 12/26/18 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 783.57 on 11/10/23 |
| High | 2.14 on 10/24/18 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,434 | 166,968,480 | 80,656,088 | 103,662,736 | 105,042,232 |
| Shares Outstanding, K | 38,690 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 44,420,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -8,100,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 10,180,000 | 8,196,000,000 | 6,686,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -4,670,000 | 767,000,000 | -4,170,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 1.86 | 0.60 | 0.22 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/14/19 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 16.21 | 29.77 | 25.27 |